Related Experiment Video
Updated: Mar 25, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3-UPF1 splicing and surveillance
Jiwon Jeong1, Dawon Hong1, Tae Young Park1
1Laboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea.
Abstract:
Dysregulated expression of tumor suppressor genes can impair their functions, even promoting oncogenesis. Expression of p53β mRNA can be regulated by alternative splicing and RNA surveillance, otherwise translated to a C-terminal truncated p53 protein with a unique neoepitope. Here, we identified that p53 introns bear the binding sites for serine and arginine-rich splicing factor 3 (SRSF3). SRSF3 binding to p53 intron 9 facilitates upstream frameshift 1 (UPF1) recruitment and regulates production of p53β mRNA. We also demonstrated that this ternary ribonucleoprotein complex forms cotranscriptionally in chromatin. SRSF3 depletion disrupts SRSF3-UPF1 axis, elevating the levels of p53β mRNA encoding a C-terminal-truncated isoform. Intriguitly, p53β protein isoform lacks tumor-suppressive activity and promotes oncogenic epithelial-mesenchymal transition through enhanced cell migration and invasion. We define the coordinated roles of the splicing factor SRSF3 and the RNA surveillance factor UPF1 in regulating p53 mRNA isoform expression, thereby linking splicing fidelity with RNA surveillance during transcription. Our findings highlight the SRSF3-UPF1 axis for preventing oncogenic p53β protein isoform accumulation, offering a potential therapeutic target to restore p53 function and impede cancer progression.
Insights
The SRSF3-UPF1 axis prevents the oncogenic p53β protein isoform. This axis links splicing and RNA surveillance, offering a therapeutic target to restore tumor suppressor p53 function and impede cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Dysregulated tumor suppressor gene expression can promote cancer.
- The p53β mRNA isoform, produced via alternative splicing, encodes a truncated protein lacking tumor-suppressive activity.
Purpose of the Study:
- To investigate the roles of splicing factor SRSF3 and RNA surveillance factor UPF1 in regulating p53 mRNA isoform expression.
- To elucidate the mechanism by which the SRSF3-UPF1 axis prevents the accumulation of the oncogenic p53β isoform.
Main Methods:
- Identified SRSF3 binding sites within p53 introns.
- Demonstrated cotranscriptional complex formation of SRSF3 and UPF1.
- Analyzed p53β mRNA and protein levels following SRSF3 depletion.
Main Results:
- SRSF3 binds to p53 intron 9, facilitating UPF1 recruitment and p53β mRNA production.
- SRSF3 depletion elevates p53β mRNA and protein levels.
- The p53β isoform promotes epithelial-mesenchymal transition, enhancing cell migration and invasion.
Conclusions:
- The SRSF3-UPF1 axis coordinates splicing and RNA surveillance to prevent oncogenic p53β isoform accumulation.
- Targeting the SRSF3-UPF1 axis may restore p53 function and inhibit cancer progression.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response

